Using ALS as an example, Hall et al. demonstrated how a diminished support capacity of patient-specific valosin-containing protein (VCP) mutant astrocytes led to a decrease in cell viability in control MNs compared with co-culture with control astrocytes [40]. The gene discussed is VCP; the disease is amyotrophic lateral sclerosis.